European study on epidemiology and management of hepatitis C virus (HCV) infection in the haemodialysis population. Part 3: prevalence and incidence.
EDTNA ERCA J
; 32(1): 42-4, 2006.
Article
en En
| MEDLINE
| ID: mdl-16700168
ABSTRACT
An analysis of the literature showed a high prevalence of HCV in the European dialysis population in the nineties. The prevalence was similar in most countries in northern Europe, but infection was more common in France, Italy, Spain, Portugal and Greece (1) and in Eastern European countries (2). The reported prevalence of anti-HCV-positive patients in the EDTA registry was 21% in 1992 and 18% in 1993 (3) ranging from 1% in Finland to 42% in Egypt (4). The incidence of HCV, in new patients starting renal replacement therapy, ranged from 3% to 7% (5,6) and reported seroconversion rates during dialysis treatment varied between 1% (7) and 16% (8) per year.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Infección Hospitalaria
/
Diálisis Renal
/
Control de Infecciones
/
Hepatitis C
Tipo de estudio:
Incidence_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
EDTNA ERCA J
Asunto de la revista:
ENFERMAGEM
/
NEFROLOGIA
Año:
2006
Tipo del documento:
Article
País de afiliación:
Italia